Trade Moderna Inc ^MRNA

Analysts Set Moderna, Inc. (NASDAQ:MRNA) Target Price at $32.33 - Stock Observer

CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, I

Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026

Jim Cramer Discusses the Moderna Rally and the Impact of FDA Leadership Changes

Analysts' Opinions Are Mixed on These Healthcare Stocks: Rocket Pharmaceuticals (RCKT) and Moderna (MRNA) | Markets Insider

Is Moderna (MRNA) Pricing Make Sense After A 96% One Year Share Price Jump

This Biotech ETF Is Still Well Below Its 2021 Peak. Analysts Say That Is Exactly Why to Buy It.

Biotech Stocks To Watch Now - April 3rd - Daily Political

Why Moderna (MRNA) Is Down 6.6% After Its 'Moderna 2.0' Cancer-Vaccine Pivot - And What's Next - Simply Wall St News

Moderna (NASDAQ:MRNA) Price Target Raised to $48.00 at Barclays

Moderna, Inc. (NASDAQ:MRNA) Given Consensus Recommendation of "Reduce" by Brokerages

Exclusive-Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles - Yahoo News UK

Biotech Stocks To Consider - April 1st - Markets Daily

Moderna (MRNA) Valuation Check As Moderna 2.0 Oncology Pivot And Legal Settlement Shift Expectations

Promising Biotech Stocks To Watch Now - March 31st - Daily Political

3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next

A Look Back at Biotechnology Stocks' Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack

MRNA: Litigation Deal And Flu Review Path Will Limit Future Upside

MRNA, SRPT, and KRYS Phase 3 Data Will Shape XBI's 2026 Performance

Moderna's Diverging Flu Vaccine Rulings May Shift mRNA Growth Story

Biotech Stocks To Keep An Eye On - March 28th - Stock Observer

Stock Traders Purchase High Volume of Call Options on Moderna (NASDAQ:MRNA) - Daily Political

Moderna Faces EMA Approval And FDA Pushback As Valuation Risks Mount

Stock Traders Purchase Large Volume of Moderna Call Options (NASDAQ:MRNA)

Azenta, 10x Genomics, PacBio, Oscar Health, and Moderna Shares Plummet, What You Need To Know

Moderna Sees Unusually High Options Volume (NASDAQ:MRNA) - Stock Observer

2 Healthcare Stocks That Could Soar Over the Next 5 Years

Metagenomi Can't Ax IPO Investor Suit Over Moderna Partnership

Assessing Whether Moderna (MRNA) Is Undervalued As Growth Plans Face Profitability Test

Therapeutics Stocks Q4 In Review: United Therapeutics (NASDAQ:UTHR) Vs Peers

Promising Biotech Stocks To Consider - March 23rd - Markets Daily

Hudson Bay Capital Management LP Lowers Stake in Moderna, Inc. $MRNA

6 years since lockdown, here's a look at COVID vaccine guidance today - Yahoo News Canada

Other voices: An erratic FDA is a threat to innovation - Twin Cities

Q4 Earnings Highlights: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest Of The Therapeutics Stocks

Therapeutics Stocks Q4 Teardown: Moderna (NASDAQ:MRNA) Vs The Rest

Promising Biotech Stocks To Follow Today - March 20th - Stock Observer

Why Moderna (MRNA) Is Down 6.4% After Cancer Vaccine Data And Flu Shot's Expedited FDA Review

Strategy Summit 2026: Why AI Means Radical Change

Biotech Stocks Worth Watching - March 18th - Markets Daily

Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks

Militia Capital Partners LP Sells 49,000 Shares of Moderna, Inc. $MRNA

FDA backpedals to review Moderna mRNA flu vaccine

Moderna (MRNA) Is Down 5.7% After Costly LNP Settlement And Multi-Pathogen Trial Update - Has The Bull Case Changed?

Moderna (MRNA) Valuation Check As Multi Pathogen mRNA Study Completion And FDA Shifts Draw Fresh Focus

Moderna (MRNA) Valuation Check After Sharp Multi‑Month Share Price Rebound

Best Biotech Stocks To Research - March 13th - Markets Daily

Spikevax (Moderna) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

Human herpesvirus evasion of humoral immunity and implications for vaccine development

Moderna Valuation Questioned As mRNA Guidance And Flu Review Shift

Moderna, Inc. $MRNA Position Increased by Theleme Partners LLP

Moderna, Inc. $MRNA Shares Bought by Theleme Partners LLP - Daily Political

A structure-based mRNA vaccine for Nipah virus in healthy adults: a phase 1 trial

Is It Too Early To Reassess Moderna (MRNA) After Its Strong 2024 Share Price Rally?

Jefferies Financial Group Inc. Sells 32,310 Shares of Moderna, Inc. $MRNA - Daily Political

This biotech's stock soared after a 'polarizing' FDA official is stepping down | Morningstar

$2.25 Billion: What Moderna Bought - Beyond Just the COVID-19 Vaccine

This biotech's stock is soaring after a 'polarizing' FDA official is stepping down | Morningstar

Quantbot Technologies LP Sells 34,481 Shares of Moderna, Inc. $MRNA

Quantbot Technologies LP Reduces Stock Holdings in Moderna, Inc. $MRNA - Stock Observer